Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Two-State Receptor Model01:29

The Two-State Receptor Model

3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.7K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.7K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SACall: A Neural Network Basecaller for Oxford Nanopore Sequencing Data Based on Self-Attention Mechanism.

IEEE/ACM transactions on computational biology and bioinformatics·2020
Same author

Identification of early mild cognitive impairment using multi-modal data and graph convolutional networks.

BMC bioinformatics·2020
Same author

DeepFrag-k: a fragment-based deep learning approach for protein fold recognition.

BMC bioinformatics·2020
Same author

Predicting unrecognized enhancer-mediated genome topology by an ensemble machine learning model.

Genome research·2020
Same author

Drug-drug similarity measure and its applications.

Briefings in bioinformatics·2020
Same author

Computational drug repositioning based on multi-similarities bilinear matrix factorization.

Briefings in bioinformatics·2020
Same journal

Multimodal Contrastive Spatiotemporal Self-Organizing Neural Networks for In-Home Activity Learning of Mild Cognitive Impairment.

IEEE journal of biomedical and health informatics·2026
Same journal

Integrating Multi-View Residue Graph and Protein Language Model for Cell-Penetrating Peptide Prediction via Global-Local Graph Aggregation and Cross-Attentive Fusion.

IEEE journal of biomedical and health informatics·2026
Same journal

An Ultra-Lightweight Cross-scale Attention Mamba Network for Accurate Skin Lesion Segmentation.

IEEE journal of biomedical and health informatics·2026
Same journal

Explanation-Guided Reconstruction of Missing Clinical Features for Survival Prediction in Pancreatic Cancer.

IEEE journal of biomedical and health informatics·2026
Same journal

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same journal

Patient-specific Biomechanical Investigation of Percutaneous Pulmonary Valves: Towards the Integration of Routinely Acquired Clinical Data and Fluid-structure Interaction Simulations.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: Jan 12, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K

BiBLDR: Bidirectional Behavior Learning for Drug Repositioning.

Renye Zhang, Mengyun Yang, Qichang Zhao

    IEEE Journal of Biomedical and Health Informatics
    |November 5, 2025
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces BiBLDR, a new deep learning framework for drug repositioning that overcomes cold-start limitations. BiBLDR uses bidirectional behavior learning to effectively predict drug-disease associations even with limited data.

    More Related Videos

    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
    08:29

    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

    Published on: June 7, 2018

    12.1K
    A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
    07:51

    A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

    Published on: June 18, 2018

    11.0K

    Related Experiment Videos

    Last Updated: Jan 12, 2026

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    10.2K
    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
    08:29

    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

    Published on: June 7, 2018

    12.1K
    A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
    07:51

    A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

    Published on: June 18, 2018

    11.0K

    Area of Science:

    • Computational biology
    • Pharmacology
    • Artificial intelligence

    Background:

    • Graph-based deep learning methods have advanced drug repositioning.
    • These methods struggle with cold-start scenarios due to reliance on known associations.
    • A need exists for robust drug repositioning strategies that handle limited data.

    Purpose of the Study:

    • To propose BiBLDR, a novel framework for drug repositioning.
    • To address the cold-start problem in drug repositioning using behavior sequence learning.
    • To improve the prediction of drug-disease associations.

    Main Methods:

    • Reformulated drug repositioning as a behavior sequence learning task.
    • Constructed bidirectional behavioral sequences for drugs and diseases.
    • Employed a two-stage strategy involving prototype spaces and sequence data for association prediction.

    Main Results:

    • BiBLDR effectively handles both drug and disease cold-start scenarios.
    • The framework captures hidden pharmacological relationships from bidirectional sequences.
    • Achieved state-of-the-art performance on benchmark datasets, outperforming existing methods in cold-start situations.

    Conclusions:

    • BiBLDR offers a robust and effective solution for drug repositioning, particularly in cold-start scenarios.
    • The bidirectional behavior learning strategy enhances feature representation and prediction accuracy.
    • This approach significantly advances the field of computational drug discovery.